Log on / register
Feedback | Support | My details
Open AccessResearch article

Myosin-Vb functions as a dynamic tether for peripheral endocytic compartments during transferrin trafficking

D William Provance Jr1 email, Erin J Addison1 email, Patrick R Wood1,2 email, David Z Chen1,3 email, Colleen M Silan1 email and John A Mercer1 email

McLaughlin Research Institute, Great Falls, MT, USA

University of Washington School of Medicine, Seattle, WA, USA

Amherst College, Amherst, MA, USA

author email corresponding author email

BMC Cell Biology 2008, 9:44doi:10.1186/1471-2121-9-44

Published: 7 August 2008

Additional files

Additional file 1:

Low-level expression of full-length eGFP-myosin-Vb (green) shows rare, dynamic colocalization (circles) of myosin-Vb and transferrin (red); same cell as shown in Figure 1D–F. Frame acquisition rate, 0.5/sec; elapsed seconds are displayed at lower right.

Format: MOV Size: 13.9MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 2:

Overexpression of full-length eGFP-myosin-Vb (green) in the presence of transferrin (red; added at the time of transfection) produces enlarged, less-motile peripheral endosomes decorated with myosin-Vb and containing transferrin at 24 h post transfection; same cells as shown in Figure 2D–F. Frame acquisition rate, 0.5/sec; elapsed seconds are displayed at lower right.

Format: MOV Size: 13.4MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 3:

Overexpression of full-length eGFP-myosin-Vb produces enlarged, less-motile peripheral endosomes decorated with myosin-Vb; same field as shown in Figure 2J–L. Frame acquisition rate, 0.5/sec; frame display rate, 3/sec.

Format: MOV Size: 1.7MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more

Additional file 4:

Overexpression of full-length eGFP-myosin-Vb (not shown) prevents entry of Alexa 546-labeled transferrin (shown) into perinuclear compartments; same field as Additional file 3. Frame acquisition rate, 0.5/sec; frame display rate, 3/sec.

Format: MOV Size: 15.8MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 5:

Overlay of Additional file 3 (myosin-Vb, green) and Additional file 4 (transferrin, red).

Format: MOV Size: 9.5MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 6:

Rab11a (red) colocalizes with eGFP-myosin-Vb (green) at high myosin-Vb expression levels. Frame acquisition rate, 0.5/sec; frame display rate, 6/sec.

Format: MOV Size: 11.5MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 7:

Rab4 (red) does not colocalize with eGFP-myosin-Vb (green) at high myosin-Vb expression levels. Frame acquisition rate, 0.5/sec; frame display rate, 6/sec.

Format: MOV Size: 11.7MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more

Additional file 8:

Rab5 (red) does not colocalize with eGFP-myosin-Vb (green) at high myosin-Vb expression levels. Frame acquisition rate, 0.5/sec; frame display rate, 6/sec.

Format: MOV Size: 19.4MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 9:

Chemical-genetic inhibition of sensitized mutant (Y119G) eGFP-myosin-Vb by PE-ADP microinjection does not prevent movement of transferrin-positive particles. Cells were loaded with fluorescent transferrin (red) 30 min before myosin-Vb was inhibited in the center cell by PE-ADP. Frame acquisition rate, 1/sec; frame display rate, 3/sec.

Format: MOV Size: 3.3MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 10:

Chemical-genetic inhibition of sensitized mutant (Y119G) eGFP-myosin-Vb by PE-ADP microinjection (cell on left) halts movement of all myosin-Vb-decorated particles, including those being transported via microtubules; same field as Figure 3A. Uninjected control cell is on the right. Frame acquisition rate, 1/sec; frame display rate, 10/sec.

Format: MOV Size: 8MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 11:

Same conditions as Additional file 10 without a control uninjected cell. Frame acquisition rate, 1/sec; frame display rate, 10/sec.

Format: MOV Size: 4.8MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


Additional file 12:

Negative control cell expressing wild-type eGFP-myosin-Vb; PE-ADP injection (immediately before imaging) does not halt movement of myosin-Vb-decorated particles. Frame acquisition rate, 1/sec; frame display rate, 10/sec.

Format: MOV Size: 7.1MB Download file

Playing the movie within this page requires QuickTime and JavaScript. Read more


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.